Pfizer Inc. (PFE)
28.00
+0.50
(+1.82%)
USD |
NYSE |
Oct 07, 16:00
27.96
-0.04
(-0.14%)
Pre-Market: 07:31
Pfizer Gross Profit Margin (Quarterly) : 62.94% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 62.94% |
| March 31, 2026 | 66.67% |
| December 31, 2025 | 62.74% |
| September 30, 2025 | 67.15% |
| June 30, 2025 | 64.29% |
| March 31, 2025 | 71.65% |
| December 31, 2024 | 73.01% |
| September 30, 2024 | 60.85% |
| June 30, 2024 | 62.06% |
| March 31, 2024 | 70.56% |
| December 31, 2023 | 41.04% |
| September 30, 2023 | 21.41% |
| June 30, 2023 | 64.67% |
| March 31, 2023 | 67.81% |
| December 31, 2022 | 55.13% |
| September 30, 2022 | 69.13% |
| June 30, 2022 | 67.32% |
| March 31, 2022 | 57.92% |
| December 31, 2021 | 55.21% |
| September 30, 2021 | 54.84% |
| June 30, 2021 | 58.49% |
| March 31, 2021 | 65.57% |
| December 31, 2020 | 68.27% |
| September 30, 2020 | 72.21% |
| June 30, 2020 | 72.81% |
| Date | Value |
|---|---|
| March 31, 2020 | 72.47% |
| December 31, 2019 | 71.50% |
| September 30, 2019 | 70.08% |
| June 30, 2019 | 71.83% |
| March 31, 2019 | 72.60% |
| December 31, 2018 | 69.27% |
| September 30, 2018 | 70.48% |
| June 30, 2018 | 69.65% |
| March 31, 2018 | 71.13% |
| December 31, 2017 | 68.00% |
| September 30, 2017 | 69.93% |
| June 30, 2017 | 70.29% |
| March 31, 2017 | 71.62% |
| December 31, 2016 | 69.33% |
| September 30, 2016 | 69.64% |
| June 30, 2016 | 69.23% |
| March 31, 2016 | 71.02% |
| December 31, 2015 | 69.37% |
| September 30, 2015 | 74.27% |
| June 30, 2015 | 74.72% |
| March 31, 2015 | 74.71% |
| December 31, 2014 | 72.60% |
| September 30, 2014 | 73.59% |
| June 30, 2014 | 73.62% |
| March 31, 2014 | 72.85% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 68.73% |
| Eli Lilly & Co. | 85.78% |
| Merck & Co., Inc. | 71.51% |
| Bristol Myers Squibb Co. | 67.95% |
| Viatris, Inc. | 41.92% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 4.92% |
| Return on Assets | 2.12% |
| Return on Invested Capital | 2.86% |
| Profit Margin (Quarterly) | -1.64% |
| Operating Margin (Quarterly) | 22.33% |
| Return on Net Operating Assets | 2.64% |